. 2016 May 21;6(6):557–563. doi: 10.1016/j.apsb.2016.04.002
© 2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 2.
Summary of identified eEF2K inhibitors.
 |